Skip to main content
Fig. 2 | BMC Gastroenterology

Fig. 2

From: Sequential transarterial chemoembolization and early radiofrequency ablation improves clinical outcomes for early-intermediate hepatocellular carcinoma in a 10-year single-center comparative study

Fig. 2

Kaplan–Meier curves for OS and TTP in the early-RFA (blue line) and late-RFA (red line) groups. a Cumulative survival probability (OS) was significantly longer (p = 0.013) in the early-RFA group (median OS: 46 months, 95% CI 38–54) than in the late-RFA group (median OS: 33 months, 95% CI 27.4–38.6). b The cumulative time to tumour progression (TTP) was significantly longer (p = 0.000) in the early RFA group (median TTP: 28 months, 95% CI 23–33 months) than in the late RFA group (median TTP: 14 months, 95% CI 7.2–20.9 months)

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us